The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exp...
The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Rationale
Two biomarkers: concentration ratio of
O
-desmethylvenlafaxine/venlafaxine and concentration sum of venlafaxine +
O
-desmethylvenlafaxine were adopted to indicate venlafaxine responses, but neither is validated.
Objectives
To evaluate the ability of two biomarkers in reflecting venlafaxine pharmacokinetic variations,...
Alternative Titles
Full title
The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1679665403
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1679665403
Other Identifiers
ISSN
0033-3158
E-ISSN
1432-2072
DOI
10.1007/s00213-014-3825-6
